DELFINI LISA (Chief Financial Officer) sold 3.1% of their position (840.00 shares) of TREVI THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/12/2023ACC: 0001209191-23-024115
Officer· Chief Financial Officer
Since Aug 2021
-840.00
Net shares
Net seller
$1.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.29K acquired · 3.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+2.29K
Price / share
$0.51
Trade value
$1.17K
% of position
9.3%
4/11/2023
24.74K→27.03K
Common Stock
Direct
Shares
−840.00
Price / share
$1.84
Trade value
$1.54K
% of position
3.1%
4/11/2023
27.03K→26.19K
Total
Net shares
+1.45K
Net value
-$373.55
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/11/2023 | M · Option Exercise | +2.29K | $0.51 | $1.17K | 9.3% | 24.74K | 27.03K |
| Common Stock Direct | 4/11/2023 | S · Sale | −840.00 | $1.84 | $1.54K | 3.1% | 27.03K | 26.19K |
| Total | +1.45K | -$373.55 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
2.29K shares
Shares
−2.29K
Strike price
0.511
Held after
77.92K
Exercisable
—
4/11/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.29K shares | 4/11/2023 | M · Option Exercise | −2.29K | 0.511 | — | 77.92K |